DexCom (DXCM) Tops Q3 EPS by 4c ; Offers Guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.60 --0%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.61, $0.04 better than the analyst estimate of $0.57. Revenue for the quarter came in at $1.21 billion versus the consensus estimate of $1.18 billion.
GUIDANCE:
DexCom sees FY2025 revenue of $4.63-4.65 billion, versus the consensus of $4.62 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
- Elauwit Connection, Inc. (ELWT) Misses Q2 EPS by 44c
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
